Effects of a neuregulin 1 variant on conversion to schizophrenia and schizophreniform disorder in people at high risk for psychosis

[1]  M. Geyer,et al.  Phenomic, Convergent Functional Genomic, and biomarker studies in a stress‐reactive genetic animal model of bipolar disorder and co‐morbid alcoholism , 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[2]  S. Cichon,et al.  A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder , 2008, Molecular Psychiatry.

[3]  A. Falini,et al.  Clock genes beyond the clock: CLOCK genotype biases neural correlates of moral valence decision in depressed patients , 2007, Genes, brain, and behavior.

[4]  K. Mossman.  The Wellcome Trust Case Control Consortium, U.K. , 2008 .

[5]  Tadafumi Kato,et al.  Animal models of bipolar disorder , 2007, Neuroscience & Biobehavioral Reviews.

[6]  M. Tsuang,et al.  Convergent Functional Genomics of bipolar disorder: From animal model pharmacogenomics to human genetics and biomarkers , 2007, Neuroscience & Biobehavioral Reviews.

[7]  N. Hayward,et al.  Expression profiling in monozygotic twins discordant for bipolar disorder reveals dysregulation of the WNT signalling pathway , 2007, Molecular Psychiatry.

[8]  W. Drevets,et al.  Sustained Low-Grade Pro-inflammatory State in Unmedicated, Remitted Women with Major Depressive Disorder as Evidenced by Elevated Serum Levels of the Acute Phase Proteins C-reactive Protein and Serum Amyloid A , 2007, Biological Psychiatry.

[9]  B. Sokolov,et al.  Oligodendroglial abnormalities in schizophrenia, mood disorders and substance abuse. Comorbidity, shared traits, or molecular phenocopies? , 2007, The international journal of neuropsychopharmacology.

[10]  Stella Dracheva,et al.  Variations in oligodendrocyte-related gene expression across multiple cortical regions: implications for the pathophysiology of schizophrenia. , 2007, The international journal of neuropsychopharmacology.

[11]  J. Nurnberger,et al.  Candidate genes, pathways and mechanisms for alcoholism: an expanded convergent functional genomics approach , 2007, The Pharmacogenomics Journal.

[12]  Simon C. Potter,et al.  Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls , 2007, Nature.

[13]  Kole T. Roybal,et al.  Mania-like behavior induced by disruption of CLOCK , 2007, Proceedings of the National Academy of Sciences.

[14]  M. Geyer,et al.  Towards Understanding The Schizophrenia Code : An Expanded Convergent Functional Genomics Approach , 2007 .

[15]  György Buzsáki,et al.  How can drug discovery for psychiatric disorders be improved? , 2007, Nature Reviews Drug Discovery.

[16]  H. Manji,et al.  Neurotrophic signaling cascades in the pathophysiology and treatment of bipolar disorder. , 2007, Current opinion in pharmacology.

[17]  B. Dean,et al.  Decreased NR1, NR2A, and SAP102 transcript expression in the hippocampus in bipolar disorder , 2007, Brain Research.

[18]  G. Kirov,et al.  Stage 2 of the Wellcome Trust UK–Irish bipolar affective disorder sibling-pair genome screen: evidence for linkage on chromosomes 6q16–q21, 4q12–q21, 9p21, 10p14–p12 and 18q22 , 2006, Molecular Psychiatry.

[19]  A. Niculescu.  Polypharmacy in oligopopulations: what psychiatric genetics can teach biological psychiatry , 2006, Psychiatric genetics.

[20]  Paul A Clemons,et al.  The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease , 2006, Science.

[21]  Nicholas J Schork,et al.  PhenoChipping of psychotic disorders: A novel approach for deconstructing and quantitating psychiatric phenotypes , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[22]  T. Steckler,et al.  Transgenic Mice Overexpressing Glycogen Synthase Kinase 3β: A Putative Model of Hyperactivity and Mania , 2006, The Journal of Neuroscience.

[23]  M. Webster,et al.  Gene expression analysis of bipolar disorder reveals downregulation of the ubiquitin cycle and alterations in synaptic genes , 2006, Molecular Psychiatry.

[24]  P. Sedgwick,et al.  Hippocampal FGF-2 and FGFR1 mRNA expression in major depression, schizophrenia and bipolar disorder , 2006, Brain Research Bulletin.

[25]  R. Myers,et al.  Mitochondrial-related gene expression changes are sensitive to agonal-pH state: implications for brain disorders , 2006, Molecular Psychiatry.

[26]  D. Chuang,et al.  Endogenous α-Synuclein Is Induced by Valproic Acid through Histone Deacetylase Inhibition and Participates in Neuroprotection against Glutamate-Induced Excitotoxicity , 2006, The Journal of Neuroscience.

[27]  R. Myers,et al.  Mitochondrial related gene expression changes are sensitive to agonal-pH state , 2006, Molecular Psychiatry.

[28]  C Henry,et al.  Genome-wide scan for genes involved in bipolar affective disorder in 70 European families ascertained through a bipolar type I early-onset proband: supportive evidence for linkage at 3p14 , 2006, Molecular Psychiatry.

[29]  B. Dean,et al.  Genome-wide expression analysis detects eight genes with robust alterations specific to bipolar I disorder: relevance to neuronal network perturbation. , 2006, Human molecular genetics.

[30]  H. Manji,et al.  Cellular Plasticity Cascades: Genes-To-Behavior Pathways in Animal Models of Bipolar Disorder , 2006, Biological Psychiatry.

[31]  R. Duman,et al.  A Neurotrophic Model for Stress-Related Mood Disorders , 2006, Biological Psychiatry.

[32]  T. Nabeshima,et al.  Mice with neuron-specific accumulation of mitochondrial DNA mutations show mood disorder-like phenotypes , 2006, Molecular Psychiatry.

[33]  Carlos A. Zarate,et al.  Cellular Plasticity Cascades: Targets for the Development of Novel Therapeutics for Bipolar Disorder , 2006, Biological Psychiatry.

[34]  L. Neckers.  Using natural product inhibitors to validate Hsp90 as a molecular target in cancer. , 2006, Current topics in medicinal chemistry.

[35]  Charles M Perou,et al.  Evaluating the comparability of gene expression in blood and brain , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[36]  R. Myers,et al.  Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[37]  Jacques Corbeil,et al.  Comparative gene expression analysis of blood and brain provides concurrent validation of SELENBP1 up-regulation in schizophrenia , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[38]  M. Daly,et al.  Combined analysis from eleven linkage studies of bipolar disorder provides strong evidence of susceptibility loci on chromosomes 6q and 8q. , 2005, American journal of human genetics.

[39]  Desmond J. Higham,et al.  GeneRank: Using search engine technology for the analysis of microarray experiments , 2005, BMC Bioinformatics.

[40]  P. Dodd,et al.  Expression of MBP, PLP, MAG, CNP, and GFAP in the Human Alcoholic Brain. , 2005, Alcoholism, clinical and experimental research.

[41]  F. Middleton,et al.  Gene expression analysis of peripheral blood leukocytes from discordant sib‐pairs with schizophrenia and bipolar disorder reveals points of convergence between genetic and functional genomic approaches , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[42]  M. Skolnick,et al.  Genome‐wide linkage analyses of extended Utah pedigrees identifies loci that influence recurrent, early‐onset major depression and anxiety disorders , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[43]  Y. Chagnon,et al.  Shared and specific susceptibility loci for schizophrenia and bipolar disorder: a dense genome scan in Eastern Quebec families , 2005, Molecular Psychiatry.

[44]  A. Shalev,et al.  Peripheral blood mononuclear cell gene expression profiles identify emergent post-traumatic stress disorder among trauma survivors , 2005, Molecular Psychiatry.

[45]  A. Niculescu.  Genomic studies of mood disorders - the brain as a muscle? , 2005, Genome Biology.

[46]  C. Aston,et al.  Original Research Article , 2004 .

[47]  Stephen J Glatt,et al.  Assessing the validity of blood‐based gene expression profiles for the classification of schizophrenia and bipolar disorder: A preliminary report , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[48]  Nora I. Perrone-Bizzozero,et al.  Altered Myelination of the Hippocampal Formation in Subjects with Schizophrenia and Bipolar Disorder , 2004, Neurochemical Research.

[49]  T. Gilliam,et al.  Linkage analysis of psychosis in bipolar pedigrees suggests novel putative loci for bipolar disorder and shared susceptibility with schizophrenia , 2004, Molecular Psychiatry.

[50]  N. Schork,et al.  Candidate genes, pathways and mechanisms for bipolar (manic–depressive) and related disorders: an expanded convergent functional genomics approach , 2004, Molecular Psychiatry.

[51]  E G Jones,et al.  Dysregulation of the fibroblast growth factor system in major depression. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[52]  Y. Nomura,et al.  Sodium 4-Phenylbutyrate Protects against Cerebral Ischemic Injury , 2004, Molecular Pharmacology.

[53]  Andrew L. Lemire,et al.  Comparison of microarray-based mRNA profiling technologies for identification of psychiatric disease and drug signatures , 2004, Journal of Neuroscience Methods.

[54]  C. Aston,et al.  Microarray analysis of postmortem temporal cortex from patients with schizophrenia , 2004, Journal of neuroscience research.

[55]  F. McMahon,et al.  Loci on chromosomes 6q and 6p interact to increase susceptibility to bipolar affective disorder in the national institute of mental health genetics initiative pedigrees , 2004, Biological Psychiatry.

[56]  T. Goldberg,et al.  Genes and the parsing of cognitive processes , 2004, Trends in Cognitive Sciences.

[57]  J. Korf,et al.  Lymphocytes as a neural probe: potential for studying psychiatric disorders , 2004, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[58]  Marquis P Vawter,et al.  Microarray screening of lymphocyte gene expression differences in a multiplex schizophrenia pedigree , 2004, Schizophrenia Research.

[59]  M. Karayiorgou,et al.  Convergent evidence for impaired AKT1-GSK3β signaling in schizophrenia , 2004, Nature Genetics.

[60]  John Quackenbush.  Microarrays--Guilt by Association , 2003, Science.

[61]  Peter B. Jones,et al.  Oligodendrocyte dysfunction in schizophrenia and bipolar disorder , 2003, The Lancet.

[62]  P. Visscher,et al.  Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: Bipolar disorder. , 2003, American journal of human genetics.

[63]  Francis J McMahon,et al.  Genomewide linkage analyses of bipolar disorder: a new sample of 250 pedigrees from the National Institute of Mental Health Genetics Initiative. , 2003, American journal of human genetics.

[64]  Philip D. Harvey,et al.  White matter changes in schizophrenia: evidence for myelin-related dysfunction. , 2003, Archives of general psychiatry.

[65]  Francis J McMahon,et al.  Suggestive linkage to chromosomal regions 13q31 and 22q12 in families with psychotic bipolar disorder. , 2003, The American journal of psychiatry.

[66]  A. Zeiher,et al.  Regulation of telomerase activity and anti‐apoptotic function by protein–protein interaction and phosphorylation , 2003, FEBS letters.

[67]  F. McMahon,et al.  Additional, physically ordered markers increase linkage signal for bipolar disorder on chromosome 18q22 , 2003, Biological Psychiatry.

[68]  John Quackenbush.  Genomics. Microarrays--guilt by association. , 2003, Science.

[69]  J. Ott,et al.  Evidence for a putative bipolar disorder locus on 2p13–16 and other potential loci on 4q31, 7q34, 8q13, 9q31, 10q21–24, 13q32, 14q21 and 17q11–12 , 2003, Molecular Psychiatry.

[70]  Xiaohua Li,et al.  Regulation of Akt and glycogen synthase kinase-3β phosphorylation by sodium valproate and lithium , 2002, Neuropharmacology.

[71]  Daniel R Weinberger,et al.  Microarray analysis of gene expression in the prefrontal cortex in schizophrenia: a preliminary study , 2002, Schizophrenia Research.

[72]  G. Zubenko,et al.  Genome survey for susceptibility loci for recurrent, early-onset major depression: results at 10cM resolution. , 2002, American journal of medical genetics.

[73]  P. Schofield,et al.  A genome screen of 13 bipolar affective disorder pedigrees provides evidence for susceptibility loci on chromosome 3 as well as chromosomes 9, 13 and 19 , 2002, Molecular Psychiatry.

[74]  M P Baur,et al.  A genome screen for genes predisposing to bipolar affective disorder detects a new susceptibility locus on 8q. , 2001, Human molecular genetics.

[75]  L. Bierut,et al.  Evidence for a locus on chromosome 1 that influences vulnerability to alcoholism and affective disorder. , 2001, The American journal of psychiatry.

[76]  S. Antonarakis,et al.  An apparently dominant bipolar affective disorder (BPAD) locus on chromosome 20p11.2–q11.2 in a large Turkish pedigree , 2001, European Journal of Human Genetics.

[77]  J. Kelsoe,et al.  Identifying a series of candidate genes for mania and psychosis: a convergent functional genomics approach. , 2000, Physiological genomics.

[78]  J. Morissette,et al.  Genome-wide search for linkage of bipolar affective disorders in a very large pedigree derived from a homogeneous population in quebec points to a locus of major effect on chromosome 12q23-q24. , 1999, American journal of medical genetics.

[79]  F. McMahon,et al.  Initial genome scan of the NIMH genetics initiative bipolar pedigrees: chromosomes 1, 6, 8, 10, and 12. , 1997, American journal of medical genetics.